AI Tool Comparison
Comparing as AI Remote Patient MonitoringCadence vs Hinge Health
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

Cadence
VS

Hinge Health
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Cadence
Hinge Health
Pricing
EnterpriseCadence is an enterprise-only platform with no public pricing. All deployments are custom contracts negotiated directly with health systems and payers.
Many Cadence programs are Medicare-reimbursable: Remote Patient Monitoring (RPM) codes and Advanced Primary Care Management (APCM) codes for qualifying Medicare patients provide a reimbursement pathway that reduces net cost for health systems. Published ROI data shows a 3:1 return to Medicare for every dollar spent.
Contact Cadence through cadence.care for health system partnership and pricing discussions.
CustomHinge Health is a B2B platform available exclusively through employer benefits contracts. It is not sold direct-to-consumer.
Pricing is primarily engagement-based \u2014 employers pay only when members actively use the program, aligning costs with actual program utilization. Approximately 80% of contracted lives are on the engagement-based model. A per-member-per-month (PMPM) model is also available.
Employer ROI is demonstrated through surgical avoidance, reduced specialist visits, and decreased musculoskeletal healthcare costs. Contact Hinge Health through hingehealth.com for employer pricing and implementation details.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity Tools
Summary
Clinical AI with supervised agents for chronic disease care — 27% fewer admissions, 3:1 Medicare ROI
Digital MSK clinic with TrueMotion AI and Enso wearable — surgical avoidance and physical therapy for employers
Cadence Pros & Cons
Pros
- Supervised AI agents automate high-volume chronic care tasks under physician oversight — unique clinical AI approach
- $100M Series C (June 2026) at $1.23B valuation — Spark Capital-backed with strong financial momentum
- 27% reduction in hospital admissions, $1,302 lower annual care cost per patient — peer-reviewed outcomes
- 3:1 Medicare ROI published — stronger economic validation than most RPM competitors
- Medicare RPM and APCM reimbursement support — reduces net cost burden on health systems
- Outcomes consistent across rural and underserved communities — proven equity in care access
- Hybrid AI + human clinical team model — AI amplifies clinicians rather than replacing them
Cons
- Enterprise health system sales cycle is long — not accessible to individual practices or small clinics
- No public pricing — all contracts custom negotiated with health systems
- Currently focused on seniors/Medicare population — less suited for younger patient populations
- 90,000+ patient scale is growing but still smaller than Teladoc or Biofourmis
- Dependent on Medicare reimbursement rates — policy changes could impact economics
- AI agents require ongoing physician supervision — not fully autonomous
Hinge Health Pros & Cons
Pros
- NYSE: HNGE, $5.29B market cap, $732M projected 2026 revenue — strongest financial position in digital MSK
- TrueMotion AI motion tracking enables real-time PT form feedback without in-person visits
- FDA-cleared Enso wearable provides medication-free pain relief via electrical nerve stimulation
- 85% of HingeSelect members choose conservative digital PT over surgery — proven surgical avoidance outcomes
- Engagement-based pricing aligns employer costs with actual member usage
- Epic EHR integration connects MSK care data with existing health system records
- Expanded to Migraine Care (2026) — platform extending beyond MSK into broader condition management
Cons
- B2B employer-only model — not directly accessible to individuals without employer coverage
- Focused exclusively on MSK conditions — not a general-purpose virtual care platform
- Engagement-based pricing can create budget uncertainty for employer clients
- Relatively recent IPO (May 2025) — limited track record as a public company
- Geographic focus primarily US — limited international availability